Associated thrombophilic defects in essential thrombocythaemia: their relationship with clinical manifestations.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019943:Amino Acid Substitution; D000990:Antithrombin III / Q000378:metabolism; D002648:Child; D005260:Female; D006801:Humans; D006918:Hydroxyurea; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011486:Protein C / Q000378:metabolism; D011516:Prothrombin / Q000235:genetics; D011799:Quinazolines / Q000627:therapeutic use; D012016:Reference Values; D013920:Thrombocythemia, Essential / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D019851:Thrombophilia / Q000150:complications
D010975:Platelet Aggregation Inhibitors; D011486:Protein C; D011799:Quinazolines; D000990:Antithrombin III; D011516:Prothrombin; C021139:anagrelide; D006918:Hydroxyurea